Literature DB >> 32093955

Novel Anatomic Predictors of New Persistent Left Bundle Branch Block After Evolut Transcatheter Aortic Valve Implantation.

Syed Zaid1, Aditya Sengupta2, Kimberly Okoli2, Melissa Tsoi1, Asaad Khan3, Hasan Ahmad1, Joshua B Goldberg4, Cenap Undemir4, Anna Rozenshtein5, Nish Patel3, Muhammad Khan3, Eisha Gupta3, Jason Kovacic3, Steven L Lansman4, George D Dangas3, Samin K Sharma3, Annapoorna Kini3, Gilbert H L Tang6.   

Abstract

New persistent left bundle branch block (NP-LBBB) has been associated with adverse outcomes after TAVI but few predictors thus far reported. We sought to identify predictors of NP-LBBB after TAVI with EvolutR/PRO (ER/EP). From 1/2016 to 4/2019, 544 patients from 2 centers underwent TAVI with Evolut (54% ER, 46% EP) for severe native aortic stenosis. Patients with previous LBBB and pacemaker were excluded. Aortic root analysis was performed using 3Mensio Valves Software and membranous septal length (MSL) was determined using the standard coronal view. Clinical, anatomic and procedural characteristics of 396 Evolut were analyzed and predictors of NP-LBBB were identified. Valve Academic Research Consortium-2 outcomes were reported. At discharge, NP-LBBB was seen in 76(19.2%) patients. NP-LBBB in Evolut was associated with implant depth at left coronary cusp (p = 0.004) and 34 mm ER (p = 0.026). Independent predictors of NP-LBBB in Evolut were shorter MSL (odds ratio [OR] = 0.82 per mm septum, 95% confidence interval [CI] = 0.68 to 0.98,p = 0.030), left ventricular outflow tract (LVOT) eccentricity (OR = 1.04 per %, 95% CI = 1.01 to 1.06,p = 0.002), implant depth at noncoronary cusp (NCC) (OR = 1.28 per mm ventricular, 95% CI = 1.11 to 1.48,p = 0.001) and annular perimeter oversizing ≥20% (OR = 2.38, 95% CI = 1.20 to 4.72, p = 0.013). On ROC curve analysis, MSL ≤6.5 mm, NCC depth ≥3 mm and LVOT eccentricity ≥35% were optimal threshold values to predict NP-LBBB. In Conclusion, shorter MSL, LVOT eccentricity, annular oversizing and deeper implant depth are novel predictors of NP-LBBB in Evolut TAVI. Preprocedural CT assessment of aortic root anatomy may help identify patients at risk for NP-LBBB. In such patients, modifying procedural factors such as higher implant and less annular oversizing may reduce the risk of NP-LBBB. Further evaluation of our hypothesis is warranted.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32093955     DOI: 10.1016/j.amjcard.2020.01.008

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  Cusp Overlap Technique: Should It Become the Standard Implantation Technique for Self-expanding Valves?

Authors:  Aditya Sengupta; Sophia L Alexis; Timothy Lee; Syed Zaid; Parasuram M Krishnamoorthy; Sahil Khera; Stamatios Lerakis; Malcolm Anastasius; George D Dangas; Samin K Sharma; Annapoorna S Kini; Gilbert H L Tang
Journal:  Curr Cardiol Rep       Date:  2021-10-01       Impact factor: 3.955

2.  The Technological Basis of a Balloon-Expandable TAVR System: Non-occlusive Deployment, Anchorage in the Absence of Calcification and Polymer Leaflets.

Authors:  Harish Appa; Kenneth Park; Deon Bezuidenhout; Braden van Breda; Bruce de Jongh; Jandré de Villiers; Reno Chacko; Jacques Scherman; Chima Ofoegbu; Justiaan Swanevelder; Michael Cousins; Paul Human; Robin Smith; Ferdinand Vogt; Bruno K Podesser; Christoph Schmitz; Lenard Conradi; Hendrik Treede; Holger Schröfel; Theodor Fischlein; Martin Grabenwöger; Xinjin Luo; Heather Coombes; Simon Matskeplishvili; David F Williams; Peter Zilla
Journal:  Front Cardiovasc Med       Date:  2022-03-03

3.  Structural Changesofthe Right Fibrous Trigone as a Risk Factor for Conduction Disturbance After Transcatheter Aortic Valve Implantation.

Authors:  Serkan Aslan; Aysel Türkvatan; Çağdaş Topel; Ahmet Güner; Ali Rıza Demir; Serkan Kahraman; Ömer Çelik; Mehmet Ertürk
Journal:  Anatol J Cardiol       Date:  2022-07       Impact factor: 1.475

4.  Outcome of transcatheter aortic valve replacement in patients over 85 years of age versus patients aged 85 and younger.

Authors:  F S van den Brink; I Wijtsma; H Amrane; T N E Vossenberg; J Haenen; F Porta; A J Van Boven; S H Hofma
Journal:  Neth Heart J       Date:  2022-05-24       Impact factor: 2.854

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.